Mifepristone as Bridge or Adjunct Therapy in the Management of Challenging Cushing Disease Cases

Establishing a definitive diagnosis of Cushing disease (CD), given its clinical and biochemical heterogeneity, initiating effective treatment to control the effects of hypercortisolism, and managing recurrence are challenging disease aspects to address. Mifepristone is a competitive glucocorticoid r...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Alice Y, Mirfakhraee, Sasan, King, Elizabeth E, Mercado, Jennifer U, Donegan, Diane M, Yuen, Kevin CJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940725/
https://www.ncbi.nlm.nih.gov/pubmed/33746521
http://dx.doi.org/10.1177/1179551421994102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940725/
https://www.ncbi.nlm.nih.gov/pubmed/33746521
http://dx.doi.org/10.1177/1179551421994102

Ejemplares similares